Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

BCLI — Brainstorm Cell Therapeutics Inc. Dilution Risk Tracker

Track BCLI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BCLI — Get alerts when the score changes →

As of October 13, 2026, Brainstorm Cell Therapeutics Inc. (BCLI) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Brainstorm Cell Therapeutics Inc. has a market capitalization of $9.38M, 11.03M shares outstanding, 5 institutional holders tracked. Stored dilution-related fields include 250.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split model est. 70%
• 50-day avg $0.78 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise model 55%
• Critical: only 0.4 months cash remaining
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track BCLI — Get forecast alerts →

Market Data

Market Cap$9.38M
Shares Outstanding11.03M
Float9.97M
Cash$218.0K
Debt$1.26M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding11.03MVerified float table or market cache
Public Float9.97MVerified float table or market cache
Market Cap$9.38MMarket data cache
Cash Runway0.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants250.0KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 4.

Recent SEC source mix: 8-K 2, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

5 institutional holders · 4.1K shares
#1 OSAIC HOLDINGS, INC. 3.6K shares
#2 Bangor Savings Bank 266 shares
#3 VSM Wealth Advisory, LLC 120 shares
+ 2 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest36.5K
Days to Cover1.4
% of Float0.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2015-03-26
8-K 8K EVENT 2026-02-27
8-K 8K EVENT 2026-02-13
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BCLI Dilution Snapshot

Brainstorm Cell Therapeutics Inc. (BCLI) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BCLI's DilutionScore has held steady at 65/100 (High risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202665/100HIGH89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track BCLI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BCLI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BCLI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations